Hu T, Rong Z, Cai C, Feng Y, et al. Impact of MRI risk assessment on the survival benefits of neoadjuvant chemoradiotherapy in patients with stage II-III rectal cancer: A retrospective cohort study. Eur J Radiol 2025;184:111954.
PMID: 39893822